Drug Research

Deals can be just as significant in the drug development industry as scientific advancements. Without mergers and acquisitions, many of today's most significant pharmaceuticals—from the anti-inflammatory Humira to the life-saving cancer medication Keytruda—might not have come to be. Pharmaceutical M&A...

On October 28th, an advisory board to the European Medicines Agency advised restricting the use of a class of medications for inflammatory diseases due to a known association with side effects like cancer and heart attacks. The group recommended limiting...

A new type of COVID-19 vaccination that is provided via inhalation rather than injection was this week introduced in Shanghai, the commercial city of China, in what is thought to be a first for the world. In September, Chinese authorities...

The necessity to update and alter the FDA's now-contentious rapid approval strategy is highlighted by the protracted, complicated FDA process to discontinue commercialization of medications that do not demonstrate safety and efficacy in mandated post-approval confirmatory studies. Over the...

According to data from the U.S. Department of Veterans Affairs (VA), a reduction in prostate cancer screening has been associated with a subsequent rise in advanced malignancies. These findings may prompt a review of the country's current testing recommendations....

Researchers discovered that by turning off the function of two genes, stomach tumours can become resistant to ATR inhibitors. As a result, genetic screening tests may one day be used to identify patients with cancers that are most likely...

The Centers for Disease Control and Prevention on October 19 advised adults in the United States to take Covid boosters from Novavax, even those who had received their primary round of doses from Pfizer, Moderna, or Johnson & Johnson. Adults 18...